THE FIGHT TO FIX PROSTATE CANCER CARE

Summary from the TLDR newsletter

Prostate cancer is the most common nonskin cancer among American men. Diagnostics and therapies for the disease generated about $12 billion to $15 billion worldwide last year. Smarter screening of prostate cancers can save lives without the harms of overtreatment. New techniques and treatments cut recovery time down to weeks, with fewer of the side effects that often follow surgery or radiation.